Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $11.0 million.

  • Medifast's Shares Outstanding (Diluted Average) rose 16.42% to $11.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $11.0 million, marking a year-over-year increase of 16.42%. This contributed to the annual value of $11.0 million for FY2025, which is 16.42% up from last year.
  • Per Medifast's latest filing, its Shares Outstanding (Diluted Average) stood at $11.0 million for Q4 2025, which was up 16.42% from $11.0 million recorded in Q3 2025.
  • Medifast's 5-year Shares Outstanding (Diluted Average) high stood at $11.9 million for Q1 2021, and its period low was $10.9 million during Q1 2023.
  • In the last 5 years, Medifast's Shares Outstanding (Diluted Average) had a median value of $11.0 million in 2025 and averaged $11.2 million.
  • Per our database at Business Quant, Medifast's Shares Outstanding (Diluted Average) crashed by 634.99% in 2023 and then surged by 84.8% in 2025.
  • Quarter analysis of 5 years shows Medifast's Shares Outstanding (Diluted Average) stood at $11.8 million in 2021, then decreased by 4.55% to $11.3 million in 2022, then dropped by 3.15% to $10.9 million in 2023, then rose by 0.38% to $11.0 million in 2024, then grew by 0.16% to $11.0 million in 2025.
  • Its last three reported values are $11.0 million in Q4 2025, $11.0 million for Q3 2025, and $11.1 million during Q2 2025.